%0 Generic
%A Rodriguez-Moreno, J. F.
%A de Velasco, G.
%A Alvarez-Fernandez, C.
%A Collado, R.
%A Fernandez-Rodriguez, R.
%A Vazquez Estevez, S.
%A Virizuela Echaburu, J. A.
%A Gajate Borau, P.
%A Font, A.
%A Lainez, N.
%A Sevillano Fernandez, E.
%A Ruiz, S.
%A Beltran, L.
%A Rodriguez-Antona, C.
%A Berraondo, P.
%A Garcia-Donas, J.
%T Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer. NEODURVARIB trial
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/27617
%~